LENALIDOMID DEVATIS

Capsule, hard, 2.5mg
RxActive license

Active substance (INN)

lenalidomide

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength2.5mg
PackagingUkupno 7 kapsula tvrdih u blisteru (1x7) u kartonskoj kutiji
ManufacturerDevatis GmbH, Germany
Therapeutic groupAntineoplastic and immunomodulating agents (L04AX04)
Marketing authorization holderDRUŠTVO SA OGRANIČENOM ODGOVORNOŠĆU "MAACPHARM"
Authorization dateMarch 5, 2026

Analogs in Montenegro

18

Other medicines with the same active substance

LENALIDOMID ALKALOIDRx
Capsule, hard, 5mgAlkaloid AD Skopje
LENALIDOMID ALKALOIDRx
Capsule, hard, 10mgAlkaloid AD Skopje
LENALIDOMID ALKALOIDRx
Capsule, hard, 15mgAlkaloid AD Skopje
LENALIDOMID ALKALOIDRx
Capsule, hard, 25mgAlkaloid AD Skopje
LENALIDOMID DEVATISRx
Capsule, hard, 5mgDevatis GmbH
LENALIDOMID DEVATISRx
Capsule, hard, 7.5mgDevatis GmbH
LENALIDOMID DEVATISRx
Capsule, hard, 15mgDevatis GmbH
LENALIDOMID DEVATISRx
Capsule, hard, 25mgDevatis GmbH
LENALIDOMID DEVATISRx
Capsule, hard, 10mgDevatis GmbH
LENALIDOMIDE ACCORDRestricted
Capsule, hard, 10mgAccord Healthcare Polska Sp. z o.o. Magazyn Importera
LENALIDOMIDE ACCORDRestricted
Capsule, hard, 25mgAccord Healthcare Polska Sp. z o.o. Magazyn Importera
LENALIDOMIDE GRINDEKSRx
Capsule, hard, 10mgGrindeks
LENALIDOMIDE GRINDEKSRx
Capsule, hard, 25mgGrindeks
REVLIMIDRx
Capsule, hard, 10mgCelgene Distribution B.V.
REVLIMIDRx
Capsule, hard, 25mgCelgene Distribution B.V.
REVLIMIDRx
Capsule, hard, 5mgCelgene Distribution B.V.
REVLIMIDRx
Capsule, hard, 15mgCelgene Distribution B.V.
REVLIMIDRx
Capsule, hard, 2.5mgCelgene Distribution B.V.
Source: CInMED register